At the beginning of Aβ pathology, microglia can exert a neuroprotective role by degrading and removing Aβ and tau, while with the evolution of AD, increasing in the size and number of amyloid plaques, the clearance ability of microglia decrease (Mawuenyega et al., 2010). This evidence concerns the gene MAPT and Alzheimer disease.